Liechtenstein Health Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Assessment of Inhibition of Biofilm Formation and Plaque Bacterial Count of Fluoride Varnish Containing Chlorhexidine and Cetylpyridinium Chloride Versus Conventional Fluoride Varnish
Condition: High Caries Risk Patients Interventions: Drug: Cervitec F, Ivoclar Vivadent - Schaan Liechtenstein; Drug: Fluor Protector, Ivoclar Vivadent - Schaan Liechtenstein Sponsor: Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials
